Form 4 for BEAM Beam Therapeutics Inc.
Accepted 2026-06-29 14:17:18 ET · period of report 2026-06-25 · accession 0001193125-26-288078 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-06-29 14:17 | 2026-06-25+ | BEAM | FMR LLC | 10%, See Remark 1 | S - Sale | $35.24 | -284.9K | 854.6K | -25% | -$10.04M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-25 | S | D | 33,372 | $35.12 | 1,106,071 | I F-Prime Capital Partners Healthcare Fund V LP | — | — | (F1) The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $35.00 to $35.39. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information. |
| 2 | Common | Common Stock | 2026-06-26 | S | D | 251,488 | $35.26 | 854,583 | I F-Prime Capital Partners Healthcare Fund V LP | — | — | (F2) The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $35.00 to $35.88. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information. |